These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30792693)

  • 1. Endocrine-Mediated Mechanisms of Metabolic Disruption and New Approaches to Examine the Public Health Threat.
    Kassotis CD; Stapleton HM
    Front Endocrinol (Lausanne); 2019; 10():39. PubMed ID: 30792693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the Utility of ToxCast-Based Predictive Models to Evaluate Potential Metabolic Disruption by Environmental Chemicals.
    Filer DL; Hoffman K; Sargis RM; Trasande L; Kassotis CD
    Environ Health Perspect; 2022 May; 130(5):57005. PubMed ID: 35533074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipogenic and endocrine disrupting mixture effects of organic and inorganic pollutant mixtures.
    Bérubé R; LeFauve MK; Heldman S; Chiang YT; Birbeck J; Westrick J; Hoffman K; Kassotis CD
    Sci Total Environ; 2023 Jun; 876():162587. PubMed ID: 36871739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
    Grün F; Blumberg B
    Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid receptor antagonism as a contributory mechanism for adipogenesis induced by environmental mixtures in 3T3-L1 cells.
    Kassotis CD; Kollitz EM; Hoffman K; Sosa JA; Stapleton HM
    Sci Total Environ; 2019 May; 666():431-444. PubMed ID: 30802659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesogens: an emerging threat to public health.
    Janesick AS; Blumberg B
    Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation.
    Sargis RM; Johnson DN; Choudhury RA; Brady MJ
    Obesity (Silver Spring); 2010 Jul; 18(7):1283-8. PubMed ID: 19927138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics.
    Sun J; Fang R; Wang H; Xu DX; Yang J; Huang X; Cozzolino D; Fang M; Huang Y
    Environ Int; 2022 Jan; 158():106941. PubMed ID: 34689039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipogenic Activity of Chemicals Used in Plastic Consumer Products.
    Völker J; Ashcroft F; Vedøy Å; Zimmermann L; Wagner M
    Environ Sci Technol; 2022 Feb; 56(4):2487-2496. PubMed ID: 35080176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
    Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
    Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the endocrine disruption potential of industrial chemicals using an integrative approach: Public databases, in vitro exposure, and modeling receptor interactions.
    Alofe O; Kisanga E; Inayat-Hussain SH; Fukumura M; Garcia-Milian R; Perera L; Vasiliou V; Whirledge S
    Environ Int; 2019 Oct; 131():104969. PubMed ID: 31310931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity III: Obesogen assays: Limitations, strengths, and new directions.
    Kassotis CD; Vom Saal FS; Babin PJ; Lagadic-Gossmann D; Le Mentec H; Blumberg B; Mohajer N; Legrand A; Munic Kos V; Martin-Chouly C; Podechard N; Langouët S; Touma C; Barouki R; Kim MJ; Audouze K; Choudhury M; Shree N; Bansal A; Howard S; Heindel JJ
    Biochem Pharmacol; 2022 May; 199():115014. PubMed ID: 35393121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Metabolism Alteration by Endocrine Disruptors in Animal Models: An Overview.
    Maradonna F; Carnevali O
    Front Endocrinol (Lausanne); 2018; 9():654. PubMed ID: 30467492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tributyltin: Advancing the Science on Assessing Endocrine Disruption with an Unconventional Endocrine-Disrupting Compound.
    Lagadic L; Katsiadaki I; Biever R; Guiney PD; Karouna-Renier N; Schwarz T; Meador JP
    Rev Environ Contam Toxicol; 2018; 245():65-127. PubMed ID: 29119384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.
    Chen JQ; Brown TR; Russo J
    Biochim Biophys Acta; 2009 Jul; 1793(7):1128-43. PubMed ID: 19348861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine disruptors: from endocrine to metabolic disruption.
    Casals-Casas C; Desvergne B
    Annu Rev Physiol; 2011; 73():135-62. PubMed ID: 21054169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative endpoint sensitivity of in vitro estrogen agonist assays.
    Dreier DA; Connors KA; Brooks BW
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):185-93. PubMed ID: 25896097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between endocrine disruptors and obesity with a focus on bisphenol A: a narrative review.
    Boudalia S; Bousbia A; Boumaaza B; Oudir M; Canivenc Lavier MC
    Bioimpacts; 2021; 11(4):289-300. PubMed ID: 34631491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.